HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INNOGEN-B

31.800

-0.420-1.30%

Volume:177.20K

Turnover:5.64M

Market Cap:14.53B

PE:-69.76

High:32.280

Open:32.220

Low:31.100

Close:32.220

52wk High:74.000

52wk Low:29.000

Shares:456.82M

HK Float Shares:420.29M

Volume Ratio:1.08

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.456

ROE:-23.27%

ROA:-11.61%

PB:19.43

PE(LYR):-69.76

PS:235.02

Loading ...

Overview Company News Filings

HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 9%

Tiger Newspress

Guangzhou Innogen Pharmaceutical (02591) Announces Monthly Return with Unchanged Share Capital

Bulletin Express

Hong Kong Stocks Hit 52-Week Highs and Lows | November 5

BRIEF-Guangzhou Innogen Pharmaceutical & Unit Subscribes For Structured Deposit Product

INNOGEN-B (02591) Subscribes to RMB105 Million Structured Deposit Product from Bank of Ningbo

Guangzhou Innogen Pharmaceutical - Co & Unit Subscribed for Structured Deposit Product From the Bank of Ningbo for RMB105 Mln in Aggregate

THOMSON REUTERS

Hong Kong Stock 52-Week Highs and Lows Statistics | October 24

Hong Kong Stock New Highs and Lows: October 15

BRIEF-Guangzhou Innogen Pharmaceutical Says Unit Subscribes To Structured Deposit For RMB105 Million

INNOGEN-B (02591): Subscribes to RMB 105 Million Structured Deposit Product

Guangzhou Innogen Pharmaceutical - Unit Subscribes to Structured Deposit for RMB105 Mln

THOMSON REUTERS

INNOGEN-B (02591) Completes First Patient Dosing in China for Phase III Clinical Trial of Core Product Isupaglutide α for Obesity and Overweight Treatment

Guangzhou Innogen Pharmaceutical Group Initiates Phase III Clinical Trial of Efsubaglutide Alfa for Obesity Treatment in China

Guangzhou Innogen Pharmaceutical Group Reports RMB 56.4 Million Revenue and RMB 122.5 Million Net Loss for First Half of 2025

Hong Kong Stock Alert | INNOGEN-B (02591) Surges Over 4% as Core Product Islatravir α Officially Enters Commercial Sales Phase in Macau

INNOGEN-B (02591) Issues First Prescription for Core Type 2 Diabetes Treatment Product in Macau at HuaBao Medical Center

Guangzhou Innogen Pharmaceutical Group Co. Ltd. Receives Regulatory Approval for Core Diabetes Treatment in Macau

Guangzhou Innogen Pharmaceutical Group Co Ltd - Receives Bla Approval for T2d Treatment in Macau

THOMSON REUTERS

BRIEF-Guangzhou Innogen Pharmaceutical's Unit On 18 August Subscribes For CMB Structured Deposit For Rmb30 Million

INNOGEN-B (02591) Subscribes to Structured Deposit Products

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02591/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"INNOGEN-B","latestPrice":31.8,"timestamp":1763091183963,"preClose":32.22,"halted":0,"volume":177200,"delay":0,"floatShares":420285370,"shares":456819349,"eps":-0.455841303402037,"marketStatus":"Trading","change":-0.42,"latestTime":"11-14 11:33:27","open":32.22,"high":32.28,"low":31.1,"amount":5640640,"amplitude":0.036623,"askPrice":31.96,"askSize":2600,"bidPrice":31.64,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-0.5781373318986613,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1763092800000},"marketStatusCode":2,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":32.22,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":1.083695,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-11.61%","roe":"-23.27%","lyrEps":-0.455841,"volumeRatio":1.083695,"shares":456819349,"dividePrice":0,"high":32.28,"amplitude":0.036623,"preClose":32.22,"low":31.1,"week52Low":29,"pbRate":"19.43","psRate":"235.02","week52High":74,"institutionHeld":0,"latestPrice":31.8,"committee":-0.733333,"eps":-0.455841303402037,"divideRate":0,"volume":177200,"delay":0,"ttmEps":-0.5781373318986613,"open":32.22,"prevYearClose":18.68,"prevWeekClose":30,"prevMonthClose":30.58,"prevQuarterClose":39.32,"fiveDayClose":30,"twentyDayClose":35.34,"sixtyDayClose":53.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2025-11-12","current":-55.723324,"percent":0.8,"low":-137.156472,"twenty":-99.491273,"median":-78.151342,"eighty":-62.098429,"high":-56.144857,"avg":-81.214339,"sd":22.256637,"marketCap":15047629356},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-12","current":-62.098429,"twenty":-99.491273,"median":-78.151342,"eighty":-62.098429,"marketCap":15047629356}],"updateTime":1763075833395},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1167719428","title":"HK Movers | Biomedical Stocks Jump With Ascletis Pharma up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167719428","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167719428?lang=en_us&edition=fundamental","pubTime":"2025-11-10 14:11","pubTimestamp":1762755100,"startTime":"0","endTime":"0","summary":"Biomedical stocks jumped in Hong Kong this afternoon. Ascletis Pharma rose 9% ; Sirnaomics rose 8%; Innogen, Kintor Pharmaceutical, and GenFleet rose 6%; Duality Biotherapeutics rose 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"afa821d7c5aabc22fa508f3ca44a801f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","09606","02591","09939","01672","02257"],"gpt_icon":0},{"id":"1198819391","title":"Guangzhou Innogen Pharmaceutical (02591) Announces Monthly Return with Unchanged Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1198819391","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198819391?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:44","pubTimestamp":1762332240,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (02591) released its monthly return for October 2025. The total authorized share capital remains RMB 456,819,349, comprising 420,285,370 H shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"1147468063","title":"Hong Kong Stocks Hit 52-Week Highs and Lows | November 5","url":"https://stock-news.laohu8.com/highlight/detail?id=1147468063","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147468063?lang=en_us&edition=fundamental","pubTime":"2025-11-05 16:42","pubTimestamp":1762332151,"startTime":"0","endTime":"0","summary":"As of the market close on November 5, 48 stocks reached 52-week highs. Among them, Yi De Investment Holdings (06182), LFG Investment Holdings (03938), and Tianrui Automotive Interior (06162) led the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B067MR52.USD","HK0000252152.HKD","LU0163747925.USD","BK1594","LU0359201612.USD","00535","IE0034224299.USD","BK1140","LU0823437842.USD","LU0128522157.USD","02587","BK1168","BK1548","IE0009570106.USD","01907","LU0737861699.HKD","00733","01133","LU2045819591.USD","06603","BK1209","BK1135","LU0211977185.USD","01707","BK1161","BK1583","BK1156","BK1591","02605","IE00B031J352.USD","BK1558","BK1547","02188","BK1149","00066","BK1604","BK1117","BK1110","IE00B031HY20.USD","IE00B97KM107.HKD","LU1981816686.USD","BK1183","01341","BK1106","02520","BK1533","BK1553","BK1227","02011","BK1601","LU1102505762.USD","02338","BK1171","LU0072462343.USD","SG9999014674.SGD","03441","BK1219","LU0173614495.USD","01247","BK1216","BK1249","01481","BK1521","IE00B0169L03.USD","LU0588546209.SGD","BK1123","01855","06166","BK1597","00204","02202","LU1102505929.USD","09922","IE00B29SXG58.USD","03883","00848","00021","03469","01780","BK1207","BK1566","LU1115378108.SGD","HK0000320223.HKD","LU0259732245.USD","00191","LU1769817179.HKD","LU2476274308.USD","00670","00844","LU0251143458.SGD","BK1096","BK1097","BK1501","BK1258","LU0328353924.USD","00599","02453","02495","BK1122","HK0000320264.USD","LU1023057109.AUD","02589","BK1105","06980","LU0359202008.SGD","08178","03808","BK1144","BK1616","LU1048596156.SGD","BK1538","LU0594300419.USD","BK1170","IE0008369823.USD","LU0672654166.SGD","01745","BK1233","LU2125910500.SGD","02777","BK1210","LU0315179316.USD","BK1166","HK0000306701.USD","03134","IE0031814852.USD","LU0228659784.USD","HK0000500386.USD","SG9999006597.SGD","06162","08080","LU2778985437.USD","LU1769817096.USD","BK1240","BK1520","BK1229","LU1224709979.USD","01238","BK1546","BK1589","SG9999003461.SGD","01416","BK1509","LU0823426308.USD","00956","LU0471298777.SGD","BK1231","LU2048586759.USD","02670","BK1237","LU0543330483.HKD","06182","LU0823426480.USD","LU0651946864.USD","LU0348788117.USD","BK1577","BK1155","BK1160","BK1222","BK1522","BK1561","BK1178","01157","09997","BK1532","BK1109","02818","BK1236","LU2488822045.USD","08005","03313","LU0307460666.USD","00813","LU0320764755.SGD","BK1205","02688","BK1587","LU0228367735.SGD","LU1051768304.USD","LU1808992512.USD","01286","03893","01680","BK1511","LU0048580855.USD","LU0205439572.USD","01660","02386","LU0287142896.SGD","BK1507","SG9999011746.SGD","LU2506952253.HKD","HK0000252160.HKD","00341","01898","06968","IE0008368742.USD","LU0029875118.USD","LU0640798160.USD","IE0032834883.USD","LU0326950275.SGD","00894","BK1148","HK0000306685.HKD","BK1215","BK1555","00830","02508","BK1514","000002","01121","01055","LU0370786039.SGD","LU0385154629.USD","BK1505","LU0106959298.USD","BK1503","LU1039395188.USD","BK1172","02048","02319","LU1439103000.SGD","LU1166156734.SGD","00425","02270","02367","BK1230","08191","00659","LU0821914370.USD","BK1124","BK1221","LU0359201885.HKD","LU0650527681.SGD","01645","LU1048588211.SGD","SG9999002828.SGD","00440","SG9999004311.SGD","01233","LU1515016050.SGD","02591","01795","BK1239","03669"],"gpt_icon":1},{"id":"2580982215","title":"BRIEF-Guangzhou Innogen Pharmaceutical & Unit Subscribes For Structured Deposit Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2580982215","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580982215?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:22","pubTimestamp":1762176140,"startTime":"0","endTime":"0","summary":"BRIEF-Guangzhou Innogen Pharmaceutical & Unit Subscribes For Structured Deposit ProductNov 3  - Guangzhou Innogen Pharmaceutical Group Co Ltd 2591.HK:CO & UNIT SUBSCRIBED FOR STRUCTURED DEPOSIT PRODUCT  FROM THE BANK OF NINGBO FOR RMB105 MILLION IN AGGREGATEFurther company coverage: 2591.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WF10W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"gpt_icon":0},{"id":"1165823028","title":"INNOGEN-B (02591) Subscribes to RMB105 Million Structured Deposit Product from Bank of Ningbo","url":"https://stock-news.laohu8.com/highlight/detail?id=1165823028","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165823028?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:48","pubTimestamp":1762170495,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that on November 3, 2025, the company and its wholly-owned subsidiary, INNOGEN Technology, jointly subscribed to a structured deposit product from Bank of Ningbo Co., Ltd. with a total principal amount of RMB105 million.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0197","LU1820825898.SGD","LU2097828805.USD","LU1794554557.SGD","BK1161","LU2097828714.EUR","LU2580892789.USD","BK0278","BK0183","LU2097828474.EUR","LU2328871848.SGD","LU1969619763.USD","LU2580892862.HKD","LU1688375341.USD","02591","SGXZ81163826.USD","BK0201","002142","LU2097828557.USD","LU2097828631.EUR","LU1655091616.SGD","SGXZ49509284.SGD","BK0028","LU1146622755.USD","BK0187","LU1720050803.USD","BK0188","LU0140636845.USD"],"gpt_icon":0},{"id":"2580379292","title":"Guangzhou Innogen Pharmaceutical - Co & Unit Subscribed for Structured Deposit Product  From the Bank of Ningbo for RMB105 Mln in Aggregate","url":"https://stock-news.laohu8.com/highlight/detail?id=2580379292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580379292?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:44","pubTimestamp":1762170266,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WF10W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"1146059585","title":"Hong Kong Stock 52-Week Highs and Lows Statistics | October 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1146059585","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146059585?lang=en_us&edition=fundamental","pubTime":"2025-10-24 16:43","pubTimestamp":1761295386,"startTime":"0","endTime":"0","summary":"As of the market close on October 24, a total of 60 stocks have reached 52-week highs. Notably, <康大食品> (00834), <五矿地产> (00230), and  (01792) achieved the highest increase rates, at 121.62%, 58.33%,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03798","01339","08311","00230","BK1155","BK1587","LU0326950275.SGD","BK1513","06190","LU1188198961.HKD","LU1102505929.USD","BK1235","LU2460026573.USD","BK1507","LU2039709279.SGD","BK1117","BK1550","IE00B031HY20.USD","BK1162","02223","LU2045819591.USD","LU1497733631.SGD","IE00BZ08YS42.EUR","BK1610","BK1171","BK1511","BK1592","BK1151","IE00BGHQDM52.EUR","00465","01651","01757","BK1104","IE0008369823.USD","00500","03070","03469","IE00BYV24P56.USD","BK1115","LU1282651121.HKD","02356","LU1102505762.USD","02477","LU1497734951.SGD","LU0463099449.HKD","LU0149534421.HKD","BK1183","01142","01176","02699","BK1168","BK1568","02358","01115","LU1813983027.USD","01221","BK1521","LU1831875114.USD","BK1560","LU1522347837.USD","BK1542","02495","BK1127","LU1048596156.SGD","LU0594300419.USD","LU0244354667.USD","03466","02591","LU1634259557.SGD","IE0008368742.USD","00408","LU1497733557.USD","03010","BK1543","LU0173614495.USD","LU0594300179.USD","LU0293314216.USD","02834","00482","01792","LU1328277881.USD","BK1109","LU1675838814.USD","01645","08239","BK1124","BK1161","BK1164","LU0287142896.SGD","LU0181495838.USD","00023","BK1167","06989","01050","01121","BK1572","IE00B543WZ88.USD","00038","LU0140636845.USD","LU1224444064.USD","08080","BK1240","IE00BMCWC346.EUR","02621","BK1227","BK1149","BK1239","BK1193","02589","BK1213","BK1175","BK1200","01429","00381","IE00BVYPNQ40.USD","LU0359202008.SGD","SG9999011746.SGD","BK1616","00875","00923","02573","BK1258","LU0605514214.HKD","BK1188","01638","IE00B031J352.USD","BK1531","01721","LU0314109678.HKD","BK1110","03145","BK1114","LU2125910500.SGD","BK1223","06698","IE0031814852.USD","IE00BZ08YT58.USD","02289","03143","08385","02011","BK1128","LU0607220059.USD","LU0359201612.USD","03398","02600","BK1231","08360","BK1174","02605","08178","BK1106","BK1212","LU0650527681.SGD","00924","IE00BPRC5H50.USD","BK1233","00440","03808","01745","BK1601","BK1548","09909","BK1195","00199","BK1582","BK1148","LU1023057109.AUD","01288","LU1634259391.SGD","03301","01959","00834","BK1096","00393","BK1589","IE00B29SXG58.USD","BK1237","BK1555","IE00BZ08YR35.GBP","IE00BVYPNP33.GBP","BK1229","00837","BK1129","LU0821914370.USD","02313","LU0828237940.HKD","IE00B5MMRT66.SGD","LU1282651048.USD"],"gpt_icon":0},{"id":"1176127932","title":"Hong Kong Stock New Highs and Lows: October 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1176127932","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176127932?lang=en_us&edition=fundamental","pubTime":"2025-10-15 16:42","pubTimestamp":1760517768,"startTime":"0","endTime":"0","summary":"As of the market close on October 15, a total of 52 stocks reached their 52-week highs. The top three gainers were 嘉宏教育 (JH EDUCATION) (01935) with a high rate of 27.72%, 高阳科技 (HI SUN TECH) (00818)...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02486","IAU","BK1500","BK1585","LU1051768304.USD","BK1228","01115","BK1556","BK1171","00914","02451","BK1229","00733","GCmain","02497","BK1505","02543","01773","LU0737861699.HKD","SGCmain","01660","09893","00471","BK1596","01837","BK1595","03483","01044","BK1117","06190","BK1227","BK1164","06603","BK1207","BK1137","BK1606","SG9999014674.SGD","GDX","BK1253","03021","BK1544","00257","BK1188","BK1144","IE0008368742.USD","NUGT","BK1558","BK1154","SG9999011746.SGD","01872","BK1237","03469","01097","BK1563","01274","BK1162","BK1514","BK1503","01808","00684","BK1198","BK1214","BK1140","BK1560","LU0287142896.SGD","LU1515016050.SGD","00924","BK1160","08549","00670","00340","SG9999001069.SGD","518880","00089","02591","BK1193","01935","LU0821914370.USD","LU1224709979.USD","BK1225","LU1048596156.SGD","01597","BK1258","LU0173614495.USD","LU0651946864.USD","BK1561","02289","01459","BK1123","03323","BK1589","LU0205439572.USD","BK1554","BK1583","BK1126","02210","02025","BK1537","00975","BK1552","BK1239","BK1148","BK1191","02688","00837","BK1135","LU1981816686.USD","01157","BK1240","MGCmain","BK1548","08536","03737","08030","01301","00314","BK1538","00818","SGUmain","03808","08111","BK1247","BK1507","LU1328615791.USD","BK1128","00639","BK1111","BK1221","00132","BK1200","01823","00631","BK1120","DUST","BK1594","BK1212","08178","01851","1OZmain","BK1235","06698","159934","BK1145","00182","BK1124","02307","GLD","BK1566","01410","IE0034224299.USD","BK1521","02680","LU2048586759.USD","SG9999001093.SGD","QOmain","02699","BK1147","BK1097"],"gpt_icon":1},{"id":"2575211980","title":"BRIEF-Guangzhou Innogen Pharmaceutical Says Unit Subscribes To Structured Deposit For RMB105 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2575211980","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575211980?lang=en_us&edition=fundamental","pubTime":"2025-10-14 22:20","pubTimestamp":1760451606,"startTime":"0","endTime":"0","summary":"BRIEF-Guangzhou Innogen Pharmaceutical Says Unit Subscribes To Structured Deposit For RMB105 MillionOct 14  - Guangzhou Innogen Pharmaceutical Group Co Ltd 2591.HK:UNIT SUBSCRIBES TO STRUCTURED DEPOSIT FOR RMB105 MILLIONFurther company coverage: 2591.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VV1AS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"gpt_icon":0},{"id":"1164907748","title":"INNOGEN-B (02591): Subscribes to RMB 105 Million Structured Deposit Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1164907748","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164907748?lang=en_us&edition=fundamental","pubTime":"2025-10-14 21:50","pubTimestamp":1760449840,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that on October 14, 2025, the company and Innogen Technology (a directly wholly-owned subsidiary of the company) subscribed to a bank structured deposit product from Ningbo Bank for a total consideration of RMB 105 million (being the total principal amount).","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2575721640","title":"Guangzhou Innogen Pharmaceutical - Unit Subscribes to Structured Deposit for RMB105 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2575721640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575721640?lang=en_us&edition=fundamental","pubTime":"2025-10-14 21:43","pubTimestamp":1760449408,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VV1AS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1138224801","title":"INNOGEN-B (02591) Completes First Patient Dosing in China for Phase III Clinical Trial of Core Product Isupaglutide α for Obesity and Overweight Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1138224801","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138224801?lang=en_us&edition=fundamental","pubTime":"2025-09-30 17:08","pubTimestamp":1759223313,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that on September 30, 2025, the company has completed the first patient dosing in China for the Phase III clinical trial of its core product, isupaglutide α, for the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4134","III","02591"],"gpt_icon":0},{"id":"2571631033","title":"Guangzhou Innogen Pharmaceutical Group Initiates Phase III Clinical Trial of Efsubaglutide Alfa for Obesity Treatment in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2571631033","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571631033?lang=en_us&edition=fundamental","pubTime":"2025-09-30 17:07","pubTimestamp":1759223253,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Initiates Phase III Clinical Trial of Efsubaglutide Alfa for Obesity Treatment in China. Guangzhou Innogen Pharmaceutical Group Co., Ltd. has announced a business update regarding its core product, Efsubaglutide Alfa, for the treatment of obesity and being overweight in the People's Republic of China. The company recently completed the first patient dosing in its Phase III clinical trial, which began in March 2025. Approximately 800 participants are expected to be enrolled in the study. Results from the clinical trial have not yet been presented, and the company has not provided a timeline for the release of future data. Guangzhou Innogen cautioned that there is no guarantee of successful development or commercialization of the product.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL7NckzL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2571811483","title":"Guangzhou Innogen Pharmaceutical Group Reports RMB 56.4 Million Revenue and RMB 122.5 Million Net Loss for First Half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2571811483","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571811483?lang=en_us&edition=fundamental","pubTime":"2025-09-29 18:18","pubTimestamp":1759141106,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Reports RMB 56.4 Million Revenue and RMB 122.5 Million Net Loss for First Half of 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Innogen Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief on September 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL4Z2mt6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"gpt_icon":0},{"id":"1158729185","title":"Hong Kong Stock Alert | INNOGEN-B (02591) Surges Over 4% as Core Product Islatravir α Officially Enters Commercial Sales Phase in Macau","url":"https://stock-news.laohu8.com/highlight/detail?id=1158729185","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158729185?lang=en_us&edition=fundamental","pubTime":"2025-09-16 10:32","pubTimestamp":1757989950,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) surged over 4%, rising 4.42% to HK$46.3 with a turnover of HK$12.5852 million as of press time. On the news front, INNOGEN-B announced that the company has been actively promoting...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YANG","HSCEI","BK4614","02591","BK1161","07226"],"gpt_icon":1},{"id":"1139178921","title":"INNOGEN-B (02591) Issues First Prescription for Core Type 2 Diabetes Treatment Product in Macau at HuaBao Medical Center","url":"https://stock-news.laohu8.com/highlight/detail?id=1139178921","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139178921?lang=en_us&edition=fundamental","pubTime":"2025-09-12 21:10","pubTimestamp":1757682617,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that the company has been actively advancing the global expansion of its core product (isupaglutide alpha) and received BLA (Biologics License Application) approval for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159891","BK1161","02591"],"gpt_icon":0},{"id":"2566980974","title":"Guangzhou Innogen Pharmaceutical Group Co. Ltd. Receives Regulatory Approval for Core Diabetes Treatment in Macau","url":"https://stock-news.laohu8.com/highlight/detail?id=2566980974","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566980974?lang=en_us&edition=fundamental","pubTime":"2025-09-12 21:06","pubTimestamp":1757682402,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co. Ltd. has announced a significant milestone in the commercialization of its Core Product for the treatment of type 2 diabetes. The company has received regulatory approval for its biologics license application  in the Macau Special Administrative Region of China. As of September 12, 2025, the first prescription for the product, Efsubaglutide Alfa, has been issued at Centro Médico HB in Macau, marking the official commencement of its commercial sale in the region. The company, however, cautions that successful market penetration is not guaranteed and advises shareholders and potential investors to exercise due care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Innogen Pharmaceutical ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nNDL8zS8J2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2566675974","title":"Guangzhou Innogen Pharmaceutical Group Co Ltd - Receives Bla Approval for T2d Treatment in Macau","url":"https://stock-news.laohu8.com/highlight/detail?id=2566675974","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566675974?lang=en_us&edition=fundamental","pubTime":"2025-09-12 21:05","pubTimestamp":1757682306,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nFWN3UZ0EZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2564843137","title":"BRIEF-Guangzhou Innogen Pharmaceutical's Unit On 18 August Subscribes For CMB Structured Deposit For Rmb30 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2564843137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564843137?lang=en_us&edition=fundamental","pubTime":"2025-09-01 22:57","pubTimestamp":1756738651,"startTime":"0","endTime":"0","summary":"BRIEF-Guangzhou Innogen Pharmaceutical's Unit On 18 August Subscribes For CMB Structured Deposit For Rmb30 MillionSept 1  - Guangzhou Innogen Pharmaceutical Group Co Ltd 2591.HK:ON 18 AUGUST, UNIT SUBSCRIBES FOR CMB STRUCTURED DEPOSIT FOR RMB30 MILLIONFurther company coverage: 2591.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nFWN3UO0BN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"1105178687","title":"INNOGEN-B (02591) Subscribes to Structured Deposit Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1105178687","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105178687?lang=en_us&edition=fundamental","pubTime":"2025-09-01 22:36","pubTimestamp":1756737374,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that on August 18, 2025, Innogen Technology (a directly wholly-owned subsidiary of the company) subscribed to a China Merchants Bank structured deposit product for a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}]}}